PLK-1 Inhibitors Market to Register Immense Growth by 2034 | DelveInsight
DelveInsight's PLK-1 Inhibitors Market Insights report includes a comprehensive understanding of current treatment practices, emerging ...
Law17h
Bristol Myers Squibb Wins Dismissal of $6.4 Billion Lawsuit Alleging Intentional Delay of Cancer Drug
UMB Bank NA filed suit against Bristol Myers in 2021, alleging the company intentionally slow-rolled the approval process for ...
FiercePharma19h
BMS skates again on $6.4B Celgene shareholder lawsuit but is still not free from another filing
For the second time in 19 months, a federal judge in New York has dismissed a lawsuit claiming that Bristol Myers Squibb slow ...
The Pharma Letter19h
Judge dismisses $6.4 billion lawsuit against Bristol Myers Squibb
Bristol Myers Squibb won a legal victory as a New York judge dismissed a $6.4 billion lawsuit filed by UMB Bank on behalf of ...
BioSpace19h
Federal Judge Dismisses $6.4B Lawsuit Against BMS Over Celgene Acquisition
District Judge Jesse Furman ruled that the plaintiff, UMB Bank, does not have standing to bring the case against Bristol ...
Plexium Announces Appointment of Jorge F. DiMartino, M.D., Ph.D. as Chief Medical Officer
Plexium, Inc. (Plexium), a leading next-generation targeted protein degradation company, today announced that it has appointed Jorge F. DiMartino, M.D., Ph.D., as Chief Medical Officer and Executive ...